Skip to content
Research Article Open access CC BY 4.0

Efficacy of Buparvaquone Treatment in Pregnant Cows Infect with Theileria Species in Sudan

E. Ibrahim, S. B. Mohammed, A. El-Ghali, D. A. Salih, S. M. Hassan, A. M. Khalid

Asian Journal of Research in Animal and Veterinary Sciences · pp. 29–37 · Published 25 Jan 2020

10.9734/ajravs/2020/v3i184

Abstract

A total of 100 pregnant cows from various private livestock farms of Al Nuba town, Al Gezira State, Sudan was selected to assess the therapeutic effect of buparvaquone in bovine theileriosis.  Theileriosis was diagnosed before treatment by blood smears and PCR.  Theileria spp. infected animals (n=96) were divided into three groups based on their gestation period; A (6 months, n=25), B (7 months, n=41) and C (8 months, n=30). Each group was subdivided into two subgroups; treated animals [T (n=68) including; TA (n=16), TB (n=28) and TC (n=24)] and non-treated animals [NT (n=28) including; NTA (n=9), NTB (n=13) and NTC (n=6)]. The subgroups TA, TB and TC were treated with buparvaquone at the dose rate of 2.5 mg/kg body weight intramuscularly. All cows were re-examined clinically and laboratory using blood smears and PCR four and six weeks after treatment. The overall recovered cows showed significant (P≤ 0.05) differences between treated and non-treated animals; the recovery percentages in treated animals (T) were 38.2% and 66.2% after 4 and 6 weeks of treatment, respectively, while in the non-treated groups (NT) the percentages were 0% and 39.3% after the same time. A variation in recovery percentage was observed among animals based on the gestation period; the recovery percentages were 18.7%, 32.1% and 58.3% after 4 weeks of treatment and 81.3%, 57.1% and 66.7% after 6 weeks of treatment for group TA, TB, and TC, respectively. The recovery percentage was 0% for NTA, NTB and NTC after 4 weeks and 33.3%, 38.5% and 50% after 6 weeks for the same groups. In conclusion, buparvaquone is quite effective against bovine theileriosis. However, it could be less effective between 6 and 8 months of pregnancy. The highest recovery percentage is found in cows in 8th and 6th months of gestation after 4 and 6 weeks of treatment, respectively.

Theileriosis buparvaquone pregnant cows Sudan.

References (25)

  1. 1 Molecular cloning: A laboratory manual [DOI]
  2. 2 Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. [DOI]
  3. 3 Pharmacokinetics of drugs in pregnancy [DOI]
  4. 4 Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance [DOI]
  5. 5 Detection of Theileria annulata in blood samples of carrier cattle by PCR [DOI]
  6. 6 Tick-borne diseases of bovines in Pakistan: major scope for future research and improved control [DOI]
  7. 7 Theilerial Species of Domestic Livestock [DOI]
  8. 8 Clinical, haematological and therapeutic studies on tropical theileriosis in water buffaloes (Bubalus bubalis) in Egypt [DOI]
  9. 9 Chemotherapeutic value of parvaquone and buparvaquone against Theileria annulata infection of cattle [DOI]
  10. 10 Treatment of East Coast fever: a comparison of parvaquone and buparvaquone [DOI]
  11. 11 The Impact of Industrial Grain Fed Livestock Production on Food Security: an extended literature review
  12. 12 Prevalence of Theileria annulata in dairy cattle in Nyala, South Darfur State, Sudan [DOI]
  13. 13 Prevalence, clinicotherapeutic and prophylactic studies on theileriosis in district Sahiwal (Pakistan).
  14. 14 Theileria Apicoplast as a Target for Chemotherapy [DOI]
  15. 15 Present status of tick-borne diseases in Sudan.
  16. 16 Current situation of tropical theileriosis in the Sudan [DOI]
  17. 17 Prevalence of ticks (Acari: Ixodidae) and Theileria annulata infection of cattle in Gezira State, Sudan [DOI]
  18. 18 Clinico-epidemiological and therapeutic aspects of bovine theileriosis.
  19. 19 Isolation, cloning and sequence analysis of lactate dehydrogenase gene from Theileria annulata may lead to design of new antitheilerial drugs [DOI]
  20. 20 A clinical trial of buparvaquone in the treatment of East Coast fever [DOI]
  21. 21 Evaluation of buparvaquone (BUTA-Kel™ KELA, Belgium) as a treatment of East Coast fever in cattle, in the peri-urban of Dar Es Salaam city, Tanzania [DOI]
  22. 22 Drug treatment during pregnancy [DOI]
  23. 23 Prescribing in pregnancy. General principles. [DOI]
  24. 24 Effect of buparvaquone on the expression of interleukin 2 receptors inTheileria annulata-infected cells [DOI]
  25. 25 Efficacy of "Butalex" (buparvaquone) in naturally affected cattle with Theileria annulata.

Cited by 3

Acute Respiratory Syndrome Mimicking Shipping Sickness in Theileria buffeli Infected Buffalo Calf

Varghese Raina, Y. Ajith, Sasi Adithya · Acta Parasitologica · 2024

BUPARVAQUONE

Muhittin USLU, Rahmi CANBAR · Bozok Veterinary Sciences · 2023

Article metrics

Real usage data collected on this platform.

19

Page views

0

PDF downloads

2

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.